Basgenbio
PrivateLast Round
Grant
Dec 22, 2025
Total Funding Raised
$13.29M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Basgenbio is a biotechnology company that provides biomarker discovery and AI-driven drug development platforms by analyzing clinico-genomic cohort data.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Government Contracts, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Basgenbio Comparables
Compare Basgenbio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VeriSIM Life | 87% | |
| QuantHealth | 84% | |
| PharmCADD Co., Ltd. | 83% |
Basgenbio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 22, 2025 | ||||
| VC Round | Dec 22, 2025 | ||||
| Grant | Aug 21, 2025 | ||||
| Series B | Jun 8, 2023 | ||||
| Series A | May 28, 2021 | ||||
Strategic | May 24, 2021 |
Basgenbio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DS Asset Management | Series A |
| Pathfinder H | VC Round |
| Celltrion | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 29, 2026
Grew 17% QoQ, from 18 to 21 employees.
- Jul 21, 2026
Grew 18% QoQ from 17 to 20 employees.
Basgenbio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Basgenbio's valuation, stock price, and market status.
Is Basgenbio a public or private company?
Basgenbio is a private company.
What is the current stock price of Basgenbio?
Basgenbio is a private company, so its shares have no public market price. Caplight tracks Basgenbio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Basgenbio worth (valuation)?
Valuation information for Basgenbio is not publicly available.
Can I buy Basgenbio stock?
Basgenbio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Basgenbio's last funding round?
Basgenbio's most recent funding round was Grant on December 22, 2025.
Who are the main investors in Basgenbio?
Key investors in Basgenbio include DS Asset Management.
Will Basgenbio IPO soon?
No public IPO plans have been announced for Basgenbio.
How can I track Basgenbio secondary market activity?
Caplight tracks bids, offers, and trades in Basgenbio's shares on secondary markets.